Copyright
©The Author(s) 2016.
World J Gastroenterol. Aug 21, 2016; 22(31): 6987-7005
Published online Aug 21, 2016. doi: 10.3748/wjg.v22.i31.6987
Published online Aug 21, 2016. doi: 10.3748/wjg.v22.i31.6987
Figure 1 Candidate biomarkers in the mechanism of action and metabolism of the drugs in the Nab-paclitaxel/gemcitabine (A) and FOLFIRINOX (B) regimens.
- Citation: Caparello C, Meijer LL, Garajova I, Falcone A, Le Large TY, Funel N, Kazemier G, Peters GJ, Vasile E, Giovannetti E. FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer. World J Gastroenterol 2016; 22(31): 6987-7005
- URL: https://www.wjgnet.com/1007-9327/full/v22/i31/6987.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i31.6987